KAIST and Checkmate Capital Complete Investment in Bredis Healthcare
Investment Accelerates Bredis’ Capacity Expansion, Integrated Platform Development and Commercialization in Korea Further...
top of page
- May 3
Kalos Medical Announces Grant Award
SEOUL, KOREA, May 3, 2023 (GLOBE NEWSWIRE) -- Kalos Medical, Inc. (“Kalos”), a developer of innovative and minimally invasive medical...
- Mar 12
Checkmate Capital Group Announces Opening of New Flagship Office in Seoul, Korea
SEOUL, Korea and PASADENA, Calif., March 12, 2023 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to...
- Mar 1
Austrianova Secures Investment from Checkmate Capital
Austrianova Secures Investment from Checkmate Capital SINGAPORE, March 02, 2023 (GLOBE NEWSWIRE) -- SG Austria (“Austrianova”), a...
- Mar 1
New Telehealth Option for Patients and Caregivers Interested in eTNS for Pediatric ADHD
NeuroSigma Announces New Telehealth Option for Patients and Caregivers Interested in eTNS for Pediatric ADHD LOS ANGELES, March 01, 2023...
- Jan 31
NeuroSigma Announces Strategic Digital Marketing Partnership with Data360
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external ...
- Dec 6, 2022
Kalos Medical Announces Promotion of Seokjoo Chang, Ph.D. to Co-Chief Executive Officer
Further Announces Engagement of Checkmate Capital Group as International Advisor LOS ANGELES and SEOUL, South Korea, Dec. 06, 2022 ...
- Nov 8, 2022
Enrollment Commences in Two Large, Double-Blind Trials of eTNS for Pediatric ADHD
Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the ...
bottom of page